Concepedia

Xin Cao

XC

9

Publications

332

Citations

9

H-Index

2016

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Nantong University

Moderna Therapeutics (United States)

Sichuan University

Xin Cao is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, vaccination, and immunology.

ORCID

Top concepts

Publications per year

2016–2024

9

Publications

9

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin et al. · Human Vaccines & Immunotherapeutics · 2020 · 145 citations · Full text

, , +19

Diabetic Nephropathy versus Diabetic Retinopathy in a Chinese Population: A Retrospective Study

Xin Cao, Xia Gong, Xiao Ma · Medical Science Monitor · 2019 · 33 citations · Full text

A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants

Shabir A. Madhi, Eric A. F. Simões, Armando Acevedo et al. · The Journal of Infectious Diseases · 2024 · 31 citations · Full text

Impact of long working hours on depressive symptoms among COVID-19 frontline medical staff: The mediation of job burnout and the moderation of family and organizational support

Chengjie Yin, Jingya Ji, Xin Cao et al. · Frontiers in Psychology · 2023 · 28 citations · Full text

Social media addiction and academic engagement as serial mediators between social anxiety and academic performance among college students

Qiaoxing Mou, Jie Zhuang, Qunhong Wu et al. · BMC Psychology · 2024 · 27 citations · Full text

Rows per page

1–5 of 9